Skip Navigation

Brain Tumor

Research: Hearn Brain Tumor Research Center

The Thomas K. Hearn, Jr. Brain Tumor Research Center established several translational brain tumor research priorities, including:

  • Discovery and development of new molecular anti-brain tumor therapies and their combination with other treatment modalities (Molecular Therapeutics Group)
  • Understanding how radiation or other treatments may cause brain injury and how the improvement in the quality of life of patients undergoing various treatments can be achieved (Modulation of Treatment-induced Brain Injury/Quality of Life Group)
  • Introduction of noninvasive means to image both normal brain and brain tumors at cellular and molecular levels, including damage evoked by and response to treatment (Bioanatomic Imaging Group) 
  • Exploiting preclinical models offered by large animals, e.g., dogs with spontaneous tumors or nonhuman primates (NHPs) for studying cognitive functions (Pre-clinical Models of Disease Group, in continuously growing collaboration with Virginia Tech).
Last Updated: 05-04-2016
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.